Abstract
The advent of clotting factor replacement therapy has significantly improved the outlook for patients with hemophilia, even those with severe disease. And new regimens are proving effective in many resistant to replacement therapy.
| Original language | English |
|---|---|
| Pages (from-to) | 72-92 |
| Number of pages | 21 |
| Journal | Hospital practice (1995) |
| Volume | 17 |
| Issue number | 10 |
| DOIs | |
| State | Published - 1982 |